1.14
price up icon4.59%   0.05
after-market Handel nachbörslich: 1.12 -0.02 -1.75%
loading
Schlusskurs vom Vortag:
$1.09
Offen:
$1.13
24-Stunden-Volumen:
40,053
Relative Volume:
0.13
Marktkapitalisierung:
$65.65M
Einnahmen:
$3.67M
Nettoeinkommen (Verlust:
$-13.83M
KGV:
-4.0714
EPS:
-0.28
Netto-Cashflow:
$-10.79M
1W Leistung:
+1.79%
1M Leistung:
-8.80%
6M Leistung:
+100.46%
1J Leistung:
-6.56%
1-Tages-Spanne:
Value
$1.12
$1.15
1-Wochen-Bereich:
Value
$1.09
$1.1694
52-Wochen-Spanne:
Value
$0.48
$1.66

Icecure Medical Ltd Stock (ICCM) Company Profile

Name
Firmenname
Icecure Medical Ltd
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
66
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-24
Name
Neueste SEC-Einreichungen
Name
ICCM's Discussions on Twitter

Vergleichen Sie ICCM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
ICCM
Icecure Medical Ltd
1.14 65.65M 3.67M -13.83M -10.79M -0.28
Medical Devices icon
ABT
Abbott Laboratories
131.73 218.91B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.05 139.37B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
348.12 134.90B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
83.37 106.90B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
70.60 41.45B 5.72B 4.17B 259.90M 6.97

Icecure Medical Ltd Aktie (ICCM) Neueste Nachrichten

pulisher
09:41 AM

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation - StreetInsider

09:41 AM
pulisher
08:47 AM

IceCure's ProSense® Featured at European Conference on Interventional Oncology with an Emphasis on Breast Cancer Cryoablation | ICCM Stock News - GuruFocus

08:47 AM
pulisher
08:30 AM

Clinical Trial Reveals Revolutionary Breast Cancer Treatment: ProSense Shows 94% Success, Zero Complications - Stock Titan

08:30 AM
pulisher
02:57 AM

IceCure Medical (NASDAQ:ICCM) Shares Down 3.1% – Time to Sell? - Defense World

02:57 AM
pulisher
Apr 10, 2025

IceCure Medical Announces Special Shareholder Meeting for May 2025 - TipRanks

Apr 10, 2025
pulisher
Mar 31, 2025

FY2027 EPS Estimates for IceCure Medical Reduced by Analyst - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

IceCure Medical (NASDAQ:ICCM) Earns Buy Rating from HC Wainwright - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

IceCure Medical Stock Dips Despite Positive ICESECRET Study Results - Zacks Investment Research

Mar 28, 2025
pulisher
Mar 28, 2025

Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer - Targeted Oncology

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target By Investing.com - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 28, 2025
pulisher
Mar 28, 2025

H.C. Wainwright maintains Buy on IceCure Medical with $2.50 target - Investing.com

Mar 28, 2025
pulisher
Mar 28, 2025

IceCure Medical Reports Growth and Awaits FDA Decision - TipRanks

Mar 28, 2025
pulisher
Mar 27, 2025

IceCure Medical Ltd’s Earnings Call: Growth Amidst Challenges - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

IceCure Medical to Report 2024 Full Year Financial & Operational Results on March 27, 2025 - PR Newswire

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses By Investing.com - Investing.com South Africa

Mar 27, 2025
pulisher
Mar 27, 2025

Earnings call transcript: Icecure Medical’s Q4 2024 sees growth in sales but wider losses - Investing.com

Mar 27, 2025
pulisher
Mar 27, 2025

IceCure Medical Reports 2024 Financial Results: 42% Growth in ProSense® Cryoablation Sales in North America - StreetInsider.com

Mar 27, 2025
pulisher
Mar 26, 2025

Earnings Outlook For Icecure Medical - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

IceCure Medical aims to bring cold cancer treatment to Vietnam - Mugglehead Magazine

Mar 25, 2025
pulisher
Mar 25, 2025

IceCure Medical (ICCM) Projected to Post Earnings on Thursday - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Results Presented at European Association of Urology Conference in Spain: 88.7% Recurrence-Free Rate - The Malaysian Reserve

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure's ICESECRET Kidney Cancer Cryoablation Study Interim Res - GuruFocus

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

IceCure reports high efficacy in kidney tumor cryoablation study - Investing.com India

Mar 24, 2025
pulisher
Mar 20, 2025

IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer - The Malaysian Reserve

Mar 20, 2025
pulisher
Mar 20, 2025

Targeting ESR1 Mutations in Breast Cancer With Novel Therapies - Targeted Oncology

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure stock tumbles after update on ProSense (ICCM:NASDAQ) - Seeking Alpha

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure Medical Ltd. Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense®? Cryoablation in Early-Stage Breast Cancer - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure Medical Expects FDA Decision on ProSense After Q1 -March 20, 2025 at 09:20 am EDT - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

IceCure nears FDA decision on breast cancer treatment By Investing.com - Investing.com UK

Mar 20, 2025
pulisher
Mar 18, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Presented at St. Gallen International Breast Cancer Conference - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Critical Survey: IceCure Medical (NASDAQ:ICCM) and Medifocus (OTCMKTS:MDFZF) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

IceCure secures patent for cryogenic pump in China By Investing.com - Investing.com Australia

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure Receives Notice of Allowance in China for Novel Cryogenic Pump for Next-Generation Cryoablation Technology - Quantisnow

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure Gets Notice of Allowance from China's Intellectual Property Regulator -March 17, 2025 at 09:07 am EDT - MarketScreener

Mar 17, 2025
pulisher
Mar 17, 2025

IceCure secures patent for cryogenic pump in China - Investing.com

Mar 17, 2025
pulisher
Mar 17, 2025

Market Sentiment Around Loss-Making IceCure Medical Ltd (NASDAQ:ICCM) - Simply Wall St

Mar 17, 2025
pulisher
Mar 15, 2025

IceCure's ProSense® Cryoablation Featured in Six Studies Present - GuruFocus.com

Mar 15, 2025
pulisher
Mar 14, 2025

Breast Cancer Patients Report Higher Satisfaction with Cryoablation - Imaging Technology News

Mar 14, 2025
pulisher
Mar 11, 2025

IceCure Medical (NASDAQ:ICCM) Trading Down 4.4% – Time to Sell? - Defense World

Mar 11, 2025

Finanzdaten der Icecure Medical Ltd-Aktie (ICCM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$97.44
price up icon 1.32%
medical_devices PHG
$24.14
price up icon 3.65%
medical_devices STE
$222.77
price up icon 1.82%
$66.33
price up icon 0.33%
$61.65
price up icon 1.93%
medical_devices EW
$70.60
price up icon 2.02%
Kapitalisierung:     |  Volumen (24h):